Dr. Chuck Clevenger

chuck-clevengerCharles Clevenger is the Chair of the Department of Pathology at Virginia Commonwealth University (VCU) in Richmond, VA, where he is the Carolyn Wingate Hyde Professor in Cancer Research. Dr. Clevenger obtained his BS in 1982, his PhD degree in 1986, and his MD degree in 1987, all from the Northwestern University. He went on to complete his postgraduate training in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania and joined the faculty at the University of Pennsylvania School Of Medicine in 1992. In 2005, Dr. Clevenger returned to Northwestern where he was the Diana, Princess of Wales Professor of Cancer Research at Northwestern University’s Feinberg School of Medicine and Leader of the Robert H. Lurie Cancer Center’s Women’s Cancer Research Program. He was recruited to VCU to lead its Pathology Department and significant build-outs of the institution’s programs in cancer biology and precision medicine. He has an active research program maintaining continuous NIH R01 funding for over 20 years and maintains his clinical practice as a cytopathologist. He is the recipient of the American Association for Cancer Research-Breast Cancer Research Foundation Translational Breast Cancer Research Award, the American Cancer Society Junior Faculty Research Award, the Pfizer Outstanding Investigator Award from the American Society for Investigative Pathology, and has received several recognitions for his education of medical students.  Dr. Clevenger first demonstrated how prolactin (PRL), a naturally occurring hormone needed for milk production, has a role in the advancement and spread of breast cancer. The research in his lab is focused on the characterization of PRL receptor signal transduction and function as it pertains to breast cancer and the translation of these discoveries to the breast cancer patient.